Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
180,181,824
-
Total 13F shares
-
86,111,898
-
Share change
-
-779,119
-
Total reported value
-
$134,344,397
-
Price per share
-
$1.56
-
Number of holders
-
76
-
Value change
-
-$2,317,455
-
Number of buys
-
34
-
Number of sells
-
38
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q4 2023
As of 31 Dec 2023,
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
86,111,898 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, BlackRock Inc., Blackstone Inc., Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, Vivo Capital, LLC, and Blue Owl Capital Holdings LP.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.